KZR Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own KZR shares is 89, representing 63.9% of the company's common stock.

SG AMERICAS SECURITIES, LLC, in the last quarter, reduced its stake in KZR by -43.98% restricting it's holding to 24.62 thousand shares of worth nearly $22.00K. PRINCIPAL FINANCIAL GROUP INC also lessened -18.97% of the KZR shares from its portfolio, reducing its holding to 21.97 thousand shares of worth $19.80K. INVESCO LTD. also shunned KZR shares holding by -5.96% last quarter which brought its holding to 19.48 thousand shares worth $17.56K.

As per its latest 13F filing, FIDELIS CAPITAL PARTNERS, LLC increased its stake in KZR by 100% in the last quarter. The institutional holder raised its holding to 27.27 thousand shares having worth more than $24.58K. MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. also added 100% more shares of KZR to its portfolio, raising its holding to 26.2 thousand shares of worth $84.09K. FEDERATED HERMES, INC. also increased its KZR shares holding by 15% which brought its holding to 23.48 thousand shares worth $21.17K.

The insider with the most stakes in KZR is Equal Talent Investments Ltd , 10 percent owner at the company. Additionally, KZR stock is highly held by 10 percent owner Morningside Venture Investments Ltd and 10 percent owner Cormorant Asset Management, LP among others.

Company executives, directors, and other insiders own 14.79% percent of Kezar Life Sciences, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which KZR insiders have sold stock, totaling 0 shares. Insiders that have sold shares include SCHILLER MARK C., MORNINGSIDE VENTURE INVESTMENTS LTD, and KAUFFMAN MICHAEL.

There have been 0 transaction(s) during the past 6-months in which Kezar Life Sciences, Inc. insiders have bought stock, totalling 0 shares

Around 0 Kezar Life Sciences, Inc. shares are held by insiders, which represents about 14.79% of KZR stock.

KZR 10 percent owner, Equal Talent Investments Ltd holds the largest portfolio of the company's shares. KZR shares owned by Equal total nearly 6.25 million.

FIDELIS CAPITAL PARTNERS, LLC is the largest institutional owner in KZR which holds 27.27 thousand shares worth $24.58K or 0.04% of the total KZR shares outstanding followed by MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. with ownership of 26.2 thousand shares representing 0.04% of the KZR ownership. SG AMERICAS SECURITIES, LLC is the third largest stakeholder with 24.62 thousand shares or 0.03% of the ownership worth more than $22.00K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the KZR is concerned, it is a stock which is optionable.

Number of KZR shares short is 177.96K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 7.30M shares of KZR are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, KZR has 4.54M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for KZR is 0.93.